molecular testing in egfr mutant driven nsclc
Published 2 years ago • 234 plays • Length 1:04Download video MP4
Download video MP3
Similar videos
-
1:01:27
molecular testing for egfr mutations: what pathologists need to know
-
4:12
clinical utility of liquid biopsy for egfr mutation
-
2:01
checkmate-722: investigating the addition of immunotherapy to chemotherapy in egfr-mutant nsclc
-
37:44
deciphering the data in egfr - mutant nsclc
-
1:21
detectability of uncommon egfr mutations in nsclc: ngs versus pcr
-
5:32
introduction to egfr inhibitors
-
2:23
therapeutic strategies for egfr-mutated lung cancer
-
5:06
front-line osimertinib significantly lengthens overall survival in egfr-mutation positive nsclc
-
43:43
webinar: going beyond egfr: evaluating technologies for molecular genetic testing in nsclc
-
2:21
osimertinib ipilimumab in egfr-mutated nsclc
-
2:05
assess trial: blood test for egfr mutation in advanced non-small cell lung cancer
-
1:25
current treatment recommendations and future directions for egfr-mutant nsclc
-
1:26
the challenge of treatment resistance in patients with advanced egfr-mutated nsclc
-
1:04
ngs provides improved identification of uncommon egfr mutations over pcr in nsclc
-
2:03
amivantamab and lazertinib in treatment-naïve egfr-mutant nsclc
-
2:45
activity of egfr tkis in patients with nsclc with uncommon egfr mutations
-
6:43
molecular testing in patients with metastatic nsclc
-
3:29
molecular testing in nsclc
-
9:30
egfr testing for nsclc
-
3:34
repeat biopsy in lung cancer patients with egfr mutation
-
1:05
advances in managing krasg12c- and egfr-mutated nsclc